Charlotte A Gaydos1, Dennis V Ferrero, John Papp. 1. Department of Medicine, Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA. cgaydos@jhmi.edu
Abstract
OBJECTIVE: To describe and review the methods for laboratory diagnosis of Chlamydia trachomatis in men. BACKGROUND: Men provide a reservoir for continued transmission of C. trachomatis to women, thus representing a population for potential targeted screening. Although there are no formal recommendations by professional organizations for screening men for chlamydia, guidance has been provided by the Centers for Disease Control and Prevention for sites wishing to screen men, who are primarily asymptomatic. METHODS: Review of the published literature for diagnostic laboratory tests for C. trachomatis in men. RESULTS: The laboratory test of choice for screening men is a nucleic acid amplification test (NAAT), and the specimen of choice is first-catch urine. The NAAT has sufficient sensitivity and specificity, and urine provides a noninvasive specimen; together, this combination provides the achievement of sensitivities of >90% to 97% and high specificity (99%). Populations of men, such as those in detention, Job Corps training, emergency departments, the military, and high schools can offer accessible target populations for easily implemented chlamydia screening. CONCLUSION: Screening more men with NAAT assays may provide the possibility of reducing the overall burden of chlamydia in both men and women.
OBJECTIVE: To describe and review the methods for laboratory diagnosis of Chlamydia trachomatis in men. BACKGROUND:Men provide a reservoir for continued transmission of C. trachomatis to women, thus representing a population for potential targeted screening. Although there are no formal recommendations by professional organizations for screening men for chlamydia, guidance has been provided by the Centers for Disease Control and Prevention for sites wishing to screen men, who are primarily asymptomatic. METHODS: Review of the published literature for diagnostic laboratory tests for C. trachomatis in men. RESULTS: The laboratory test of choice for screening men is a nucleic acid amplification test (NAAT), and the specimen of choice is first-catch urine. The NAAT has sufficient sensitivity and specificity, and urine provides a noninvasive specimen; together, this combination provides the achievement of sensitivities of >90% to 97% and high specificity (99%). Populations of men, such as those in detention, Job Corps training, emergency departments, the military, and high schools can offer accessible target populations for easily implemented chlamydia screening. CONCLUSION: Screening more men with NAAT assays may provide the possibility of reducing the overall burden of chlamydia in both men and women.
Authors: C A Gaydos; C P Cartwright; P Colaninno; J Welsch; J Holden; S Y Ho; E M Webb; C Anderson; R Bertuzis; L Zhang; T Miller; G Leckie; K Abravaya; J Robinson Journal: J Clin Microbiol Date: 2010-07-28 Impact factor: 5.948
Authors: P R Kerndt; D V Ferrero; G Aynalem; D Monga; S Wang; N Zhang; C Wong; M Liggins; Q Meng Journal: J Clin Microbiol Date: 2011-02-09 Impact factor: 5.948
Authors: Laura Dize; Patricia Agreda; Nicole Quinn; Mathilda R Barnes; Yu-Hsiang Hsieh; Charlotte A Gaydos Journal: Sex Transm Infect Date: 2012-10-23 Impact factor: 3.519
Authors: Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos Journal: J Clin Microbiol Date: 2009-04-22 Impact factor: 5.948
Authors: Charlotte A Gaydos; Barbara Van Der Pol; Mary Jett-Goheen; Mathilda Barnes; Nicole Quinn; Carey Clark; Grace E Daniel; Paula B Dixon; Edward W Hook Journal: J Clin Microbiol Date: 2013-03-06 Impact factor: 5.948